{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:28:54Z","timestamp":1788175734372,"version":"build-2803163510"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003786","name":"Hangzhou Science and Technology Commission","doi-asserted-by":"publisher","award":["202004A14"],"award-info":[{"award-number":["202004A14"]}],"id":[{"id":"10.13039\/501100003786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LQ24H030008"],"award-info":[{"award-number":["LQ24H030008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LGF21H310004"],"award-info":[{"award-number":["LGF21H310004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key R&D Plan in Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03048"],"award-info":[{"award-number":["2024C03048"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.biopha.2024.117080","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:16:18Z","timestamp":1720278978000},"page":"117080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma"],"prefix":"10.1016","volume":"177","author":[{"given":"Sijia","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangbin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117080_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.117080_bib2","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2024.117080_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12876-016-0527-z","article-title":"Increasing mortality in the United States from cholangiocarcinoma: an analysis of the national center for health statistics database","volume":"16","author":"Yao","year":"2016","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2024.117080_bib4","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/cancers14092137","article-title":"Changing landscape of systemic therapy in biliary tract cancer","volume":"14","author":"Woods","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.117080_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","article-title":"Liver resection and transplantation for intrahepatic cholangiocarcinoma","volume":"72","author":"Mazzaferro","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117080_bib6","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1002\/cncr.29619","article-title":"Can hepatic resection provide a long-term cure for patients with intrahepatic cholangiocarcinoma?","volume":"121","author":"Spolverato","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","article-title":"Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target","volume":"77","author":"Alvisi","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117080_bib9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/14728222.2011.628937","article-title":"Targeting the Fas\/FasL signaling pathway in cancer therapy","volume":"16","author":"Villa-Morales","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2024.117080_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14838-3","article-title":"Activation of Fas\/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells","volume":"7","author":"Carnevale","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117080_bib13","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1158\/0008-5472.CAN-14-1848","article-title":"Fas ligand deficiency impairs tumor immunity by promoting an accumulation of monocytic myeloid-derived suppressor cells","volume":"75","author":"Peyvandi","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117080_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ccell.2024.02.013","article-title":"Long-lasting mRNA-encoded interleukin-2 restores CD8+ T cell neoantigen immunity in MHC class I-deficient cancers","volume":"42","author":"Beck","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.117080_bib15","article-title":"Tumor microenvironment responsive CD8+ T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor AB680-based synergistic therapy for pancreatic cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci. Weinh. Baden. Wurtt. Ger."},{"key":"10.1016\/j.biopha.2024.117080_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2023-331342","article-title":"Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8+ T cell-mediated antitumour immunity and improves anti-PD-1 efficacy","volume":"73","author":"Cai","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.117080_bib17","article-title":"High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma","volume":"4","author":"Cheng","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73 Suppl 1","author":"Fabris","year":"2021","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biopha.2024.117080_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12935-021-02081-w","article-title":"Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients","volume":"21","author":"Deng","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.biopha.2024.117080_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0560.2010.01506.x","article-title":"The biologic importance of tumor-infiltrating lymphocytes","volume":"37 Suppl 1","author":"Hodi","year":"2010","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.biopha.2024.117080_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ctm2.11","article-title":"The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome","volume":"10","author":"Zheng","year":"2020","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jhep.2019.05.026","article-title":"Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules","volume":"71","author":"Zhou","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117080_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12957-020-02082-5","article-title":"PD-1\/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome","volume":"18","author":"Tian","year":"2020","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00595-020-01967-y","article-title":"Prognostic impact of CD8+ T cell distribution and its association with the HLA class I expression in intrahepatic cholangiocarcinoma","volume":"50","author":"Asahi","year":"2020","journal-title":"Surg. Today"},{"key":"10.1016\/j.biopha.2024.117080_bib26","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/bjc.2013.610","article-title":"Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer","volume":"109","author":"Goeppert","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4143\/crt.2020.704","article-title":"Spatial distribution and prognostic implications of tumor-infiltrating FoxP3- CD4+ T cells in biliary tract cancer","volume":"53","author":"Kim","year":"2021","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2024.117080_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014","volume":"26","author":"Salgado","year":"2015","journal-title":"Ann. Oncol.\u00a0J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib29","first-page":"127","article-title":"The role of tumor-infiltrating lymphocytes in cholangiocarcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.biopha.2024.117080_bib30","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.7150\/jca.63235","article-title":"Mucin 1 promotes tumor progression through activating WNT\/\u03b2-catenin signaling pathway in intrahepatic cholangiocarcinoma","volume":"12","author":"Song","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/hep.29296","article-title":"aPKC-\u03b9\/P-Sp1\/Snail signaling induces epithelial-mesenchymal transition and immunosuppression in cholangiocarcinoma","volume":"66","author":"Qian","year":"2017","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biopha.2024.117080_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110091","article-title":"MUC1 induces the accumulation of Foxp3+ Treg cells in the tumor microenvironment to promote the growth and metastasis of cholangiocarcinoma through the EGFR\/PI3K\/Akt signaling pathway","volume":"118","author":"Zhang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117080_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.32222","article-title":"Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma","volume":"75","author":"Zimmer","year":"2022","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biopha.2024.117080_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104295","article-title":"MDSCs in liver cancer: a critical tumor-promoting player and a potential therapeutic target","volume":"361","author":"Ma","year":"2021","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses","volume":"22","author":"Sakaguchi","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","article-title":"Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases","volume":"30","author":"Ohkura","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.biopha.2024.117080_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbrc.2015.01.067","article-title":"Downregulation of FOXP3 inhibits invasion and immune escape in cholangiocarcinoma","volume":"458","author":"Ma","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2024.117080_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.727","article-title":"Forkhead box M1 recruits FoxP3(+) Treg cells to induce immune escape in hilar cholangiocarcinoma","volume":"10","author":"Ma","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.biopha.2024.117080_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2019.11.021","article-title":"MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR\/PI3K\/AKT pathways","volume":"72","author":"Tiemin","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biopha.2024.117080_bib40","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/bjc.2015.337","article-title":"Major histocompatibility complex class I expression impacts on patient survival and type and density of immune cells in biliary tract cancer","volume":"113","author":"Goeppert","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib41","first-page":"158","article-title":"Characterisation of the immune-related transcriptome in resected biliary tract cancers","volume":"86","author":"Ghidini","year":"2017","journal-title":"Eur. J. Cancer Oxf. Engl. 1990"},{"key":"10.1016\/j.biopha.2024.117080_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-020-0205-z","article-title":"Tumor-induced neurogenesis and immune evasion as targets of innovative anti-cancer therapies","volume":"5","author":"Cervantes-Villagrana","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.117080_bib43","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41590-018-0217-9","article-title":"LAG-3 inhibits the activation of CD4+ T cells that recognize stable pMHCII through its conformation-dependent recognition of pMHCII","volume":"19","author":"Maruhashi","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aah4569","article-title":"LAG3 limits regulatory T cell proliferation and function in autoimmune diabetes","volume":"2","author":"Zhang","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib45","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1073\/pnas.1003345107","article-title":"Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer","volume":"107","author":"Matsuzaki","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2024.117080_bib46","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117080_bib47","first-page":"1477","article-title":"Molecular profile of tumor-specific CD8+ T cell hypofunction in a transplantable murine cancer model","volume":"197","author":"Waugh","year":"2016","journal-title":"J. Immunol. Baltim. Md 1950"},{"key":"10.1016\/j.biopha.2024.117080_bib48","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ymthe.2022.05.003","article-title":"LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation","volume":"30","author":"Sung","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.biopha.2024.117080_bib49","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40425-019-0554-8","article-title":"HHLA2 in intrahepatic cholangiocarcinoma: an immune checkpoint with prognostic significance and wider expression compared with PD-L1","volume":"7","author":"Jing","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12079-020-00563-6","article-title":"In silico analyses of the tumor microenvironment highlight tumoral inflammation, a Th2 cytokine shift and a mesenchymal stem cell-like phenotype in advanced in basal cell carcinomas","volume":"14","author":"Lefran\u00e7ois","year":"2020","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2024.117080_bib52","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cncr.27788","article-title":"High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery","volume":"119","author":"Shi","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.immuni.2016.01.008","article-title":"The Wnt antagonist dickkopf-1 promotes pathological type 2 cell-mediated inflammation","volume":"44","author":"Chae","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658097","article-title":"Dickkopf-1: a promising target for cancer immunotherapy","volume":"12","author":"Chu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib55","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1084\/jem.20130281","article-title":"Down-regulation of PLC\u03b32-\u03b2-catenin pathway promotes activation and expansion of myeloid-derived suppressor cells in cancer","volume":"210","author":"Capietto","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib56","first-page":"208","article-title":"DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.","volume":"43","author":"Jarman","year":"2023","journal-title":"Liver Int.\u00a0J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.biopha.2024.117080_bib57","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1245\/s10434-012-2268-8","article-title":"Intratumoral IL-17+ cells and neutrophils show strong prognostic significance in intrahepatic cholangiocarcinoma","volume":"19","author":"Gu","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pharep.2017.07.017","article-title":"Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen","volume":"70","author":"Wongsena","year":"2018","journal-title":"Pharmacol. Rep. PR"},{"key":"10.1016\/j.biopha.2024.117080_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.705378","article-title":"CTLA-4 synergizes With PD1\/PD-L1 in the inhibitory tumor microenvironment of intrahepatic cholangiocarcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib60","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib61","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41590-018-0207-y","article-title":"NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death","volume":"19","author":"Huang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15129","article-title":"The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion","volume":"8","author":"Jiang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2024.117080_bib63","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1158\/1078-0432.CCR-15-3071","article-title":"HHLA2, a new immune checkpoint member of the B7 family, is widely expressed in human lung cancer and associated with egfr mutational status","volume":"23","author":"Cheng","year":"2017","journal-title":"Clin. Cancer Res.\u00a0J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117080_bib64","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1158\/1078-0432.CCR-17-2924","article-title":"Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1-negative human lung cancers","volume":"24","author":"Cheng","year":"2018","journal-title":"Clin. Cancer Res. . J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117080_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41590-019-0577-9","article-title":"The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity","volume":"21","author":"Lu","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-019-0779-5","article-title":"Immune checkpoint inhibitors of PD-L1 as cancer therapeutics","volume":"12","author":"Akinleye","year":"2019","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173960","article-title":"Inhibition of T-cell-mediated immune response via the PD-1\/ PD-L1 axis in cholangiocarcinoma cells","volume":"897","author":"Suriyo","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117080_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12967-017-1150-7","article-title":"COX-2 expression positively correlates with PD-L1 expression in human melanoma cells","volume":"15","author":"Botti","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173240","article-title":"Regulation of PD-1 in T cells for cancer immunotherapy","volume":"881","author":"Yu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.117080_bib70","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1245\/s10434-016-5101-y","article-title":"Program death 1 immune checkpoint and tumor microenvironment: implications for patients with intrahepatic cholangiocarcinoma","volume":"23","author":"Gani","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","article-title":"The importance of exosomal PDL1 in tumour immune evasion","volume":"20","author":"Daassi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/bst.2019.01003","article-title":"Programmed death ligand-1, tumor infiltrating lymphocytes and HLA expression in Chinese extrahepatic cholangiocarcinoma patients: possible immunotherapy implications","volume":"13","author":"Yu","year":"2019","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.biopha.2024.117080_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106006","article-title":"Gemcitabine enhances cytotoxic activity of effector T-lymphocytes against chemo-resistant cholangiocarcinoma cells","volume":"78","author":"Sawasdee","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.117080_bib75","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41590-019-0429-7","article-title":"Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer","volume":"20","author":"Wang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib76","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib77","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/cncr.34552","article-title":"The clinicopathological significance and relapse predictive role of tumor microenvironment of intrahepatic cholangiocarcinoma after radical surgery","volume":"129","author":"Zheng","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4+ T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib80","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2024.117080_bib81","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2024.117080_bib82","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"Clemente","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib83","article-title":"PI3K-CCL2-CCR2-MDSCs axis: a potential pathway for tumor Clostridia-promoted CD 8+ T lymphocyte infiltration in bile tract cancers","volume":"43","author":"Ma","year":"2023","journal-title":"Neoplasia N. Y. N."},{"key":"10.1016\/j.biopha.2024.117080_bib84","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1158\/2159-8290.CD-21-1077","article-title":"Mutant IDH inhibits IFN\u03b3-TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma","volume":"12","author":"Wu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2024.117080_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12957-023-03009-6","article-title":"Prognostic values of tissue-resident CD8+T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"21","author":"Chen","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib86","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/2326-6066.CIR-19-1024","article-title":"Tumor-derived IL33 promotes tissue-resident CD8+ T cells and is required for checkpoint blockade tumor immunotherapy","volume":"8","author":"Chen","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2024.117080_bib87","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/2159-8290.CD-23-0282","article-title":"An inflammatory checkpoint generated by IL1RN splicing offers therapeutic opportunity for KRAS-mutant intrahepatic cholangiocarcinoma","volume":"13","author":"Zhang","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.biopha.2024.117080_bib88","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 Costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.982196","article-title":"Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib90","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","article-title":"CD4+ T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness","volume":"47","author":"Ahrends","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib91","article-title":"Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer","volume":"344","author":"E","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib92","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41586-023-06482-x","article-title":"CRISPR screens decode cancer cell pathways that trigger \u03b3\u03b4 T cell detection","volume":"621","author":"Mamedov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2024.117080_bib93","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1080","article-title":"\u03b3\u03b4 T cells in cancer: a small population of lymphocytes with big implications","volume":"8","author":"Raverdeau","year":"2019","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib95","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.immuni.2014.03.013","article-title":"\u03b3\u03b4T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer","volume":"40","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib96","doi-asserted-by":"crossref","unstructured":"Pro- versus Antitumor \u03b3\u03b4 T-cell Activity Is Distinguished by TCR-V\u03b3\u03b4 Use, Cancer Discov. 12 (2022) 2015. https:\/\/doi.org\/10.1158\/2159-8290.CD-RW2022-134.","DOI":"10.1158\/2159-8290.CD-RW2022-134"},{"key":"10.1016\/j.biopha.2024.117080_bib97","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/cmi.2012.39","article-title":"What lessons can be learned from \u03b3\u03b4 T cell-based cancer immunotherapy trials?","volume":"10","author":"Fourni\u00e9","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1333926","article-title":"High immune cell infiltration predicts improved survival in cholangiocarcinoma","volume":"14","author":"Wirta","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-022-01253-z","article-title":"Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses","volume":"15","author":"Xia","year":"2022","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41416-022-01838-y","article-title":"Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma","volume":"127","author":"Konishi","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib101","article-title":"Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma","volume":"118","author":"Y","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib102","doi-asserted-by":"crossref","first-page":"20034","DOI":"10.18632\/oncotarget.25050","article-title":"Prognostic impact of programmed cell death ligand 1 (PD-L1) expression and its association with epithelial-mesenchymal transition in extrahepatic cholangiocarcinoma","volume":"9","author":"Ueno","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.117080_bib103","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2024.117080_bib104","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.117080_bib105","first-page":"290","article-title":"circHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma","volume":"40","author":"Xu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.biopha.2024.117080_bib106","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/bjc.2015.427","article-title":"Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"113","author":"McCoy","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cdd.2013.67","article-title":"Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer","volume":"21","author":"Bracci","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2024.117080_bib108","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12967-022-03424-5","article-title":"Single-cell landscape of immunocytes in patients with extrahepatic cholangiocarcinoma","volume":"20","author":"Xu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib109","article-title":"Enhancing cholangiocarcinoma immunotherapy with adoptive T cells targeting HLA-restricted neoantigen peptides derived from driver gene mutations, Biomed. Pharmacother","volume":"168","author":"Panya","year":"2023","journal-title":"Biomedecine Pharm."},{"key":"10.1016\/j.biopha.2024.117080_bib110","first-page":"764","article-title":"Implication of CD69(+) CD103(+) tissue-resident-like CD8(+) T cells as a potential immunotherapeutic target for cholangiocarcinoma","volume":"41","author":"Kim","year":"2021","journal-title":"Liver Int.\u00a0J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.biopha.2024.117080_bib111","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PPO.0000000000000061","article-title":"Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation","volume":"20","author":"Sanmamed","year":"2014","journal-title":"Cancer J. Sudbury Mass"},{"key":"10.1016\/j.biopha.2024.117080_bib112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2326","article-title":"Inhibitory B7-family molecules in the tumour microenvironment","volume":"8","author":"Zou","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib113","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000308","article-title":"Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib114","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbcan.2017.10.007","article-title":"Triple negative breast cancer: key role of tumor-associated macrophages in regulating the activity of anti-PD-1\/PD-L1 agents","volume":"1869","author":"Santoni","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2017.01097","article-title":"Regulation of human macrophage M1-M2 polarization balance by hypoxia and the triggering receptor expressed on myeloid cells-1","volume":"8","author":"Raggi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2024.117080_bib116","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/hep4.1682","article-title":"Inhibition of CMTM4 sensitizes cholangiocarcinoma and hepatocellular carcinoma to T cell-mediated antitumor immunity through PD-L1","volume":"6","author":"Chui","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.biopha.2024.117080_bib117","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00262-020-02746-x","article-title":"Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40\/CD40L on dendritic cells","volume":"70","author":"Sadeghlar","year":"2021","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.biopha.2024.117080_bib118","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.immuni.2019.11.003","article-title":"PD-L1:CD80 Cis-heterodimer triggers the Co-stimulatory receptor CD28 while repressing the inhibitory PD-1 and CTLA-4 pathways","volume":"51","author":"Zhao","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2024.117080_bib119","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aav7062","article-title":"Restriction of PD-1 function by cis-PD-L1\/CD80 interactions is required for optimal T cell responses","volume":"364","author":"Sugiura","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib120","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.31466","article-title":"Transcriptome profiling identifies TIGIT as a marker of T-cell exhaustion in liver cancer","volume":"73","author":"Ostroumov","year":"2021","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.biopha.2024.117080_bib121","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-cell transfer therapy targeting mutant KRAS in cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.117080_bib122","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aak9510","article-title":"Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer","volume":"356","author":"Stevanovi\u0107","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib123","article-title":"A library-based screening method identifies neoantigen-reactive T cells in peripheral blood prior to relapse of ovarian cancer","volume":"7","author":"Martin","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biopha.2024.117080_bib124","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12943-018-0840-y","article-title":"Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy","volume":"17","author":"Pang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib125","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1038\/s41598-021-85747-9","article-title":"Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma","volume":"11","author":"Supimon","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.117080_bib126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-016-0378-7","article-title":"Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma","volume":"10","author":"Feng","year":"2017","journal-title":"J. Hematol. Oncol. J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib127","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-17-0432","article-title":"Phase I study of chimeric antigen receptor-modified T cells in patients with EGFR-positive advanced biliary tract cancers","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Cancer Res.\u00a0J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.biopha.2024.117080_bib128","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cac2.12452","article-title":"Enhancement of CAR-T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins","volume":"43","author":"Qiao","year":"2023","journal-title":"Cancer Commun. Lond. Engl."},{"key":"10.1016\/j.biopha.2024.117080_bib129","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2024.117080_bib130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41416-018-0199-2","article-title":"Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma","volume":"120","author":"Goeppert","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117080_bib131","article-title":"Translatome and transcriptome co-profiling reveals a role of TPRXs in human zygotic genome activation","volume":"378","author":"Z","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.117080_bib132","article-title":"Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice","volume":"8","author":"M","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224009648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:31:21Z","timestamp":1782174681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224009648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":132,"alternative-id":["S0753332224009648"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117080","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-infiltrating T lymphocytes: A promising immunotherapeutic target for preventing immune escape in cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117080"}}